Atrial Flutter Epidemiology Forecast 2026-2035

Parameter

Insight

Largest Patient Pool

United States

Fastest Growing Region

Asia

High-Risk Population

Older adults, particularly men and individuals with cardiovascular or pulmonary comorbidities

Key Diagnostic Method

12-lead electrocardiography (ECG), supported by electrophysiological assessment when required

Major Risk Factor

Structural cardiovascular disease and advancing age

Major gap in the market

Under-recognition of AFL, coexistence with AF, and persistent thromboembolic risk after apparently successful rhythm treatment

Epidemiology Segment

Key Insights

Diagnosed Prevalent Cases of the Disease

According to the population-based study by Granada et al., 181 incident AFL cases were identified among 58,820 residents during four years of ascertainment, corresponding to 88 cases per 100,000 person-years. Atrial flutter alone accounted for approximately 37 per 100,000 person-years, while many patients also experienced AF.

Gender-Specific Cases of the Disease

According to Granada et al., atrial flutter was approximately 2.5 times more common in men than women. Age-adjusted incidence was approximately 125 per 100,000 in men versus 59 per 100,000 in women.

Age-Specific Cases of the Disease

Atrial flutter is strongly age-dependent. Granada et al. reported incidence increasing from 5 per 100,000 among individuals younger than 50 years to 587 per 100,000 among those older than 80 years. Heart failure and chronic pulmonary disease further increased risk.

Ethnicity-Wise Cases of the Disease

Contemporary epidemiological evidence demonstrates geographic and ethnic variation in the broader AF/AFL burden, but robust AFL-only ethnicity-specific prevalence estimates are limited. U.S. mortality analyses for combined AF/AFL demonstrate significant racial differences, with non-Hispanic White populations having higher recorded mortality but faster increases among non-Hispanic Black populations in some settings. These findings concern AF/AFL combined, not isolated AFL.

Mortality and Survival Analysis of the Disease

Atrial flutter is associated with clinically significant long-term mortality. In the Marshfield population study, AFL alone was independently associated with increased late mortality (HR 1.7; 95% CI 1.2–2.6) compared with controls.

Disease Type

Prevalence

Typical / CTI-Dependent Atrial Flutter

Typical CTI-dependent AFL is the principal clinical form and involves a macro-reentrant circuit traversing the cavotricuspid isthmus. It is generally highly amenable to catheter ablation. Contemporary electrophysiology consensus identifies CTI ablation as the recommended treatment because of its high procedural effectiveness and relatively low complication burden.

Atypical / Non-CTI-Dependent Atrial Flutter

Atypical AFL comprises diverse macro-reentrant circuits that do not depend on the CTI and is frequently encountered after previous AF ablation, cardiac surgery, or in the presence of atrial scar. A 2025 EHRA survey reported that 67.6% of electrophysiologists considered catheter ablation first-line therapy for atypical AFL, although mapping and ablation strategies vary considerably.

Post-Ablation / Scar-Related Atrial Flutter

Post-procedural AFL can arise from atrial scar or gaps in previous ablation lines, particularly following AF ablation. These arrhythmias can be technically complex because the re-entry circuit may involve the mitral isthmus, left atrial roof, or regions of atrial scar. The 2024 international ablation consensus recognizes CTI-dependent flutter as mechanistically linked to AF and emphasizes appropriate identification and treatment during AF ablation.

Idiopathic Atypical Atrial Flutter

Idiopathic atypical AFL occurs without previous cardiac surgery, AF ablation, or recognized structural heart disease and represents a smaller clinical subgroup. A 2024 Japanese study found atrial scar in all 22 patients with idiopathic atypical AFL undergoing ablation and reported a higher subsequent risk of cardiovascular adverse outcomes compared with CTI-dependent AFL.

Country

Key Insights

United States

The United States has the strongest classic population-based evidence for AFL-only incidence. Granada et al. reported 88 cases per 100,000 person-years, with incidence reaching 587 per 100,000 among individuals >80 years and being approximately 2.5 times higher in men.

Germany

Germany has population-based evidence on atrial fibrillation/atrial flutter, although contemporary AFL-only estimates remain limited. In the German Heinz Nixdorf Recall Study, 4,814 participants aged 45–75 years were evaluated, with AF/AFL prevalence of 3.2% overall, including 4.3% among men and 2.1% among women. Over a median 16.7-year follow-up, the incidence rate was 9.4 per 1,000 person-years, demonstrating a substantial arrhythmia burden in the German population.

France

France contributes substantially to European AF/AFL epidemiological surveillance, but a directly comparable contemporary national incidence estimate specifically for isolated AFL is not sufficiently established. European GBD analyses demonstrate a substantial burden of combined AF/AFL across Western Europe, with higher absolute incidence than Central and Eastern European regions.

Italy

Italy forms part of the substantial European AF/AFL disease burden, but current population-level publications generally report AF and AFL together. Consequently, a precise national AFL-only prevalence or incidence figure should not be stated without a dedicated Italian AFL cohort or registry. European GBD data demonstrate persistent and substantial AF/AFL incidence, prevalence, mortality, and DALY burden across the region.

Spain

Spain contributes to the European AF/AFL burden, but robust contemporary national AFL-only epidemiological estimates are limited. Available European GBD analyses demonstrate substantial country-level heterogeneity in combined AF/AFL incidence, prevalence, mortality, and DALYs

United Kingdom

The United Kingdom has substantial evidence concerning AF/AFL hospitalizations and cardiovascular outcomes, but contemporary national estimates frequently combine AF and AFL. Therefore, a specific AFL-only incidence figure should not be inferred from combined AF/AFL statistics.

Japan

Japan has substantial electrophysiological research on AFL, including contemporary studies of atypical AFL. A 2024 Japanese cohort of patients undergoing AFL ablation identified 89 patients, including 22 with idiopathic atypical AFL and 67 with CTI-dependent AFL; idiopathic atypical AFL was associated with greater subsequent cardiovascular risk. PubMed However, a contemporary nationwide AFL-only prevalence estimate is not sufficiently established.

India

India represents a large potential population for AFL because of its substantial cardiovascular risk-factor burden, but reliable contemporary nationwide AFL-only prevalence and incidence estimates are limited. GBD analyses indicate a very large, combined AF/AFL burden in India, with India among the countries contributing the highest absolute numbers of AF/AFL cases. These estimates should not be represented as AFL-only figures.